International Clinical Trial: Microbiota-Metabolism-Transcription Crosstalk and Single-Cell Spatial Mechanisms in Esophageal Squamous Cell Carcinoma

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128604) titled 'Microbiota-Metabolism-Transcription Crosstalk and Single-Cell Spatial Mechanisms in Esophageal Squamous Cell Carcinoma' on July 22.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: Huai'an First People's Hospital

Condition: Esophageal Squamous Cell Carcinoma

Intervention: Tumor group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-07-22

Target Sample Size: Tumor group:70;Adjacent normal group:70;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=333385

Disclaimer: Curated by HT Syndic...